Nordstjernan to invest in Lideta Hälsovård
Nordstjernan has reached an agreement with the founding Larsson/Lewné family on acquiring a majority of the shares in Lideta Hälsovård (“Lideta”). Dr. Simon Larsson and Hugo Lewné will remain as shareholders in Lideta, and Mr. Lewné will also remain as CEO.
Lideta engages in primary care via 15 units in Stockholm and southern Sweden. The company has grown rapidly since it was founded in 2001 by Dr. Larsson. The company currently has 93,000 listed patients, 350 employees and sales of approximately SEK 500 million. Over the last few years, Lideta has grown through acquisitions and invested in various digital initiatives to increase the accessibility and efficiency of primary care.
Tomas Billing, CEO of Nordstjernan, says:
“Nordstjernan sees a major future need of high-quality private health care. We are becoming the majority shareholder in Lideta, a well-managed company, with the ambition of being part of and developing a high-quality company in Swedish health care over many years.”
Hugo Lewné, CEO of Lideta, says:
“We are very pleased to get Nordstjernan as majority shareholder in Lideta. Our family looks forward to continuing to develop the company together with Nordstjernan.”
Lideta is Nordstjernan’s third investment in the care and health care sector. Since 2007, Nordstjernan has owned Etac, a global medical aid company whose offerings include products for people with impaired mobility. In 2015, Nordstjernan invested in the listed care company Attendo and is now the company’s largest shareholder.
Nordstjernan has a long tradition as an active shareholder in listed and private companies. Nordstjernan was founded in 1890 and its major shareholder is the Axel and Margaret Ax:son Johnson Foundation for Public Benefit.
The transaction is subject to approval from the relevant competition authorities, which is expected during the fourth quarter of 2017.
The parties have agreed not to publish the terms of the transaction.
Tomas Billing
President and CEO
Nordstjernan AB
Questions will be answered by:
Tomas Billing, CEO, Nordstjernan
Telephone: +46 8 788 50 18
E-mail: tomas.billing@nordstjernan.se
Hugo Lewné, CEO, Lideta Hälsovård
Telephone: +46 42 453 04 90
E-mail: hugo@lideta.se
Nordstjernan is a family-controlled investment company that creates growth in value through long-term and active ownership of Nordic companies. More information about Nordstjernan is available at www.nordstjernan.se.
Lideta Hälsovård is a medical care company that engages in primary care in Stockholm and southern Sweden. More information about Lideta is available at www.lideta.se.
Tags: